ID   GDE_HUMAN               Reviewed;        1532 AA.
AC   P35573; A6NCX7; A6NEK2; D3DT51; P78354; P78544; Q59H92; Q6AZ90;
AC   Q9UF08;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   17-OCT-2006, sequence version 3.
DT   10-MAY-2017, entry version 172.
DE   RecName: Full=Glycogen debranching enzyme;
DE   AltName: Full=Glycogen debrancher;
DE   Includes:
DE     RecName: Full=4-alpha-glucanotransferase;
DE              EC=2.4.1.25;
DE     AltName: Full=Oligo-1,4-1,4-glucantransferase;
DE   Includes:
DE     RecName: Full=Amylo-alpha-1,6-glucosidase;
DE              Short=Amylo-1,6-glucosidase;
DE              EC=3.2.1.33;
DE     AltName: Full=Dextrin 6-alpha-D-glucosidase;
GN   Name=AGL; Synonyms=GDE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE (ISOFORM 5).
RC   TISSUE=Muscle;
RX   PubMed=1374391;
RA   Yang B.-Z., Ding J.-H., Enghild J.J., Bao Y., Chen Y.-T.;
RT   "Molecular cloning and nucleotide sequence of cDNA encoding human
RT   muscle glycogen debranching enzyme.";
RL   J. Biol. Chem. 267:9294-9299(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RX   PubMed=8954797; DOI=10.1006/geno.1996.0611;
RA   Bao Y., Dawson T.L. Jr., Chen Y.-T.;
RT   "Human glycogen debranching enzyme gene (AGL): complete structural
RT   organization and characterization of the 5' flanking region.";
RL   Genomics 38:155-165(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RC   TISSUE=Liver;
RX   PubMed=9332391; DOI=10.1016/S0378-1119(97)00291-6;
RA   Bao Y., Yang B.-Z., Dawson T.L. Jr., Chen Y.-T.;
RT   "Isolation and nucleotide sequence of human liver glycogen debranching
RT   enzyme mRNA: identification of multiple tissue-specific isoforms.";
RL   Gene 197:389-398(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1), AND VARIANTS.
RX   PubMed=10982190; DOI=10.1007/s004390051017;
RA   Okubo M., Horinishi A., Takeuchi M., Suzuki Y., Sakura N.,
RA   Hasegawa Y., Igarashi T., Goto K., Tahara H., Uchimoto S., Omichi K.,
RA   Kanno H., Hayasaka K., Murase T.;
RT   "Heterogeneous mutations in the glycogen-debranching enzyme gene are
RT   responsible for glycogen storage disease type IIIa in Japan.";
RL   Hum. Genet. 106:108-115(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   UBIQUITINATION, CHARACTERIZATION OF VARIANT GSD3 ARG-1448, INTERACTION
RP   WITH NHLRC1, AND SUBCELLULAR LOCATION.
RX   PubMed=17908927; DOI=10.1101/gad.1553207;
RA   Cheng A., Zhang M., Gentry M.S., Worby C.A., Dixon J.E., Saltiel A.R.;
RT   "A role for AGL ubiquitination in the glycogen storage disorders of
RT   Lafora and Cori's disease.";
RL   Genes Dev. 21:2399-2409(2007).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   VARIANT GSD3 ARG-1448, AND VARIANT ARG-1115.
RX   PubMed=10571954;
RX   DOI=10.1002/(SICI)1098-1004(199912)14:6<542::AID-HUMU15>3.0.CO;2-0;
RA   Okubo M., Kanda F., Horinishi A., Takahashi K., Okuda S., Chihara K.,
RA   Murase T.;
RT   "Glycogen storage disease type IIIa: first report of a causative
RT   missense mutation (G1448R) of the glycogen debranching enzyme gene
RT   found in a homozygous patient.";
RL   Hum. Mutat. 14:542-543(1999).
CC   -!- FUNCTION: Multifunctional enzyme acting as 1,4-alpha-D-glucan:1,4-
CC       alpha-D-glucan 4-alpha-D-glycosyltransferase and amylo-1,6-
CC       glucosidase in glycogen degradation.
CC   -!- CATALYTIC ACTIVITY: Transfers a segment of a (1->4)-alpha-D-glucan
CC       to a new position in an acceptor, which may be glucose or a
CC       (1->4)-alpha-D-glucan.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of (1->6)-alpha-D-glucosidic branch
CC       linkages in glycogen phosphorylase limit dextrin.
CC   -!- SUBUNIT: Monomer. Interacts with NHLRC1/malin.
CC       {ECO:0000269|PubMed:17908927}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17908927}.
CC       Note=Under glycogenolytic conditions localizes to the nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=2, 3, 4;
CC         IsoId=P35573-1; Sequence=Displayed;
CC         Note=The products of the mRNAs termed isoforms 1 to 4 are
CC         identical.;
CC       Name=5;
CC         IsoId=P35573-2; Sequence=VSP_004270;
CC       Name=6;
CC         IsoId=P35573-3; Sequence=VSP_004271;
CC         Note=Ref.2 (AAB48470) sequence is in conflict in position:
CC         4:I->L. {ECO:0000305};
CC   -!- TISSUE SPECIFICITY: Liver, kidney and lymphoblastoid cells express
CC       predominantly isoform 1; whereas muscle and heart express not only
CC       isoform 1, but also muscle-specific isoform mRNAs (isoforms 2, 3
CC       and 4). Isoforms 5 and 6 are present in both liver and muscle.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:17908927}.
CC   -!- DISEASE: Glycogen storage disease 3 (GSD3) [MIM:232400]: A
CC       metabolic disorder associated with an accumulation of abnormal
CC       glycogen with short outer chains. It is clinically characterized
CC       by hepatomegaly, hypoglycemia, short stature, and variable
CC       myopathy. Glycogen storage disease type 3 includes different
CC       forms: GSD type 3A patients lack glycogen debrancher enzyme
CC       activity in both liver and muscle, while GSD type 3B patients are
CC       enzyme-deficient in liver only. In rare cases, selective loss of
CC       only 1 of the 2 debranching activities, glucosidase or
CC       transferase, results in GSD type 3C or type 3D, respectively.
CC       {ECO:0000269|PubMed:10571954, ECO:0000269|PubMed:17908927}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycogen debranching enzyme family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD92104.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M85168; AAB41040.1; -; mRNA.
DR   EMBL; U84007; AAB48466.1; -; mRNA.
DR   EMBL; U84008; AAB48467.1; -; mRNA.
DR   EMBL; U84009; AAB48468.1; -; mRNA.
DR   EMBL; U84010; AAB48469.1; -; mRNA.
DR   EMBL; U84011; AAB48470.1; -; mRNA.
DR   EMBL; AB035443; BAA88405.1; -; Genomic_DNA.
DR   EMBL; AB208867; BAD92104.1; ALT_INIT; mRNA.
DR   EMBL; AC096949; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW72985.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72982.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72983.1; -; Genomic_DNA.
DR   EMBL; CH471097; EAW72987.1; -; Genomic_DNA.
DR   EMBL; BC078663; AAH78663.1; -; mRNA.
DR   CCDS; CCDS759.1; -. [P35573-1]
DR   CCDS; CCDS760.1; -. [P35573-3]
DR   RefSeq; NP_000019.2; NM_000028.2. [P35573-1]
DR   RefSeq; NP_000633.2; NM_000642.2. [P35573-1]
DR   RefSeq; NP_000634.2; NM_000643.2. [P35573-1]
DR   RefSeq; NP_000635.2; NM_000644.2. [P35573-1]
DR   RefSeq; NP_000637.2; NM_000646.2. [P35573-3]
DR   RefSeq; XP_005270614.1; XM_005270557.2. [P35573-1]
DR   UniGene; Hs.904; -.
DR   ProteinModelPortal; P35573; -.
DR   BioGrid; 106686; 52.
DR   IntAct; P35573; 11.
DR   MINT; MINT-2802883; -.
DR   STRING; 9606.ENSP00000294724; -.
DR   BindingDB; P35573; -.
DR   ChEMBL; CHEMBL5272; -.
DR   CAZy; GH13; Glycoside Hydrolase Family 13.
DR   CAZy; GH133; Glycoside Hydrolase Family 133.
DR   iPTMnet; P35573; -.
DR   PhosphoSitePlus; P35573; -.
DR   BioMuta; AGL; -.
DR   DMDM; 116242491; -.
DR   EPD; P35573; -.
DR   MaxQB; P35573; -.
DR   PaxDb; P35573; -.
DR   PeptideAtlas; P35573; -.
DR   PRIDE; P35573; -.
DR   Ensembl; ENST00000294724; ENSP00000294724; ENSG00000162688. [P35573-1]
DR   Ensembl; ENST00000361915; ENSP00000355106; ENSG00000162688. [P35573-1]
DR   Ensembl; ENST00000370161; ENSP00000359180; ENSG00000162688. [P35573-3]
DR   Ensembl; ENST00000370163; ENSP00000359182; ENSG00000162688. [P35573-1]
DR   Ensembl; ENST00000370165; ENSP00000359184; ENSG00000162688. [P35573-1]
DR   GeneID; 178; -.
DR   KEGG; hsa:178; -.
DR   UCSC; uc001dsi.2; human. [P35573-1]
DR   CTD; 178; -.
DR   DisGeNET; 178; -.
DR   GeneCards; AGL; -.
DR   GeneCards; ENSG00000283495; -.
DR   GeneReviews; AGL; -.
DR   HGNC; HGNC:321; AGL.
DR   HPA; HPA028498; -.
DR   HPA; HPA054340; -.
DR   MalaCards; AGL; -.
DR   MalaCards; ENSG00000283495; -.
DR   MIM; 232400; phenotype.
DR   MIM; 610860; gene.
DR   neXtProt; NX_P35573; -.
DR   OpenTargets; ENSG00000162688; -.
DR   OpenTargets; ENSG00000283495; -.
DR   Orphanet; 366; Glycogen storage disease due to glycogen debranching enzyme deficiency.
DR   PharmGKB; PA24618; -.
DR   eggNOG; KOG3625; Eukaryota.
DR   eggNOG; COG3408; LUCA.
DR   GeneTree; ENSGT00390000012596; -.
DR   HOVERGEN; HBG005824; -.
DR   InParanoid; P35573; -.
DR   KO; K01196; -.
DR   OMA; PCLRPLM; -.
DR   OrthoDB; EOG091G00L5; -.
DR   PhylomeDB; P35573; -.
DR   TreeFam; TF300697; -.
DR   BioCyc; MetaCyc:HS08717-MONOMER; -.
DR   BRENDA; 3.2.1.33; 2681.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-70221; Glycogen breakdown (glycogenolysis).
DR   GeneWiki; Glycogen_debranching_enzyme; -.
DR   GenomeRNAi; 178; -.
DR   PRO; PR:P35573; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162688; -.
DR   CleanEx; HS_AGL; -.
DR   ExpressionAtlas; P35573; baseline and differential.
DR   Genevisible; P35573; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:1904813; C:ficolin-1-rich granule lumen; TAS:Reactome.
DR   GO; GO:0016234; C:inclusion body; IEA:Ensembl.
DR   GO; GO:0043033; C:isoamylase complex; TAS:ProtInc.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0016529; C:sarcoplasmic reticulum; IEA:Ensembl.
DR   GO; GO:0034774; C:secretory granule lumen; TAS:Reactome.
DR   GO; GO:0004134; F:4-alpha-glucanotransferase activity; EXP:Reactome.
DR   GO; GO:0004135; F:amylo-alpha-1,6-glucosidase activity; EXP:Reactome.
DR   GO; GO:0004133; F:glycogen debranching enzyme activity; TAS:ProtInc.
DR   GO; GO:0030247; F:polysaccharide binding; IEA:Ensembl.
DR   GO; GO:0031593; F:polyubiquitin binding; IEA:Ensembl.
DR   GO; GO:0005978; P:glycogen biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0005980; P:glycogen catabolic process; IBA:GO_Central.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0051384; P:response to glucocorticoid; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; IEA:Ensembl.
DR   CDD; cd11327; AmyAc_Glg_debranch_2; 1.
DR   InterPro; IPR008928; 6-hairpin_glycosidase-like.
DR   InterPro; IPR010401; AGL/Gdb1.
DR   InterPro; IPR032788; AGL_central.
DR   InterPro; IPR029436; AGL_euk_N.
DR   InterPro; IPR032792; AGL_glucanoTrfase.
DR   InterPro; IPR032790; GDE_C.
DR   InterPro; IPR006421; Glycogen_debranch_met.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   PANTHER; PTHR10569; PTHR10569; 1.
DR   Pfam; PF06202; GDE_C; 1.
DR   Pfam; PF14701; hDGE_amylase; 1.
DR   Pfam; PF14702; hGDE_central; 1.
DR   Pfam; PF14699; hGDE_N; 1.
DR   SUPFAM; SSF48208; SSF48208; 2.
DR   SUPFAM; SSF51445; SSF51445; 2.
DR   TIGRFAMs; TIGR01531; glyc_debranch; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Disease mutation; Glycogen biosynthesis;
KW   Glycogen storage disease; Glycosidase; Glycosyltransferase; Hydrolase;
KW   Multifunctional enzyme; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Ubl conjugation.
FT   CHAIN         1   1532       Glycogen debranching enzyme.
FT                                /FTId=PRO_0000087450.
FT   REGION        1      ?       4-alpha-glucanotransferase.
FT   REGION        ?   1532       Amylo-1,6-glucosidase.
FT   ACT_SITE    526    526       {ECO:0000250}.
FT   ACT_SITE    529    529       {ECO:0000250}.
FT   ACT_SITE    627    627       {ECO:0000250}.
FT   MOD_RES      64     64       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ       1     27       MGHSKQIRILLLNEMEKLEKTLFRLEQ -> MSLLTCAFYL
FT                                (in isoform 5). {ECO:0000305}.
FT                                /FTId=VSP_004270.
FT   VAR_SEQ       1     27       MGHSKQIRILLLNEMEKLEKTLFRLEQ -> MAPILSINLF
FT                                I (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_004271.
FT   VARIANT      38     38       T -> A (in dbSNP:rs35278779).
FT                                /FTId=VAR_032084.
FT   VARIANT     229    229       Q -> R (in dbSNP:rs17121403).
FT                                /FTId=VAR_028051.
FT   VARIANT     387    387       R -> Q (in dbSNP:rs17121464).
FT                                /FTId=VAR_009621.
FT   VARIANT     701    701       A -> S (in dbSNP:rs3736297).
FT                                /FTId=VAR_028052.
FT   VARIANT     962    962       S -> C (in dbSNP:rs34714252).
FT                                /FTId=VAR_032085.
FT   VARIANT    1067   1067       P -> S (in dbSNP:rs3753494).
FT                                /FTId=VAR_020389.
FT   VARIANT    1115   1115       G -> R (in dbSNP:rs2230307).
FT                                {ECO:0000269|PubMed:10571954}.
FT                                /FTId=VAR_009230.
FT   VARIANT    1144   1144       I -> N (in dbSNP:rs2230308).
FT                                /FTId=VAR_028053.
FT   VARIANT    1207   1207       A -> T (in dbSNP:rs11807956).
FT                                /FTId=VAR_051010.
FT   VARIANT    1253   1253       R -> H (in dbSNP:rs12043139).
FT                                /FTId=VAR_028054.
FT   VARIANT    1343   1343       E -> K (in dbSNP:rs112795811).
FT                                /FTId=VAR_009622.
FT   VARIANT    1448   1448       G -> R (in GSD3; deficient in ability to
FT                                bind glycogen; unstable due to enhanced
FT                                ubiquitination; forms aggresomes upon
FT                                proteasome impairment;
FT                                dbSNP:rs118203964).
FT                                {ECO:0000269|PubMed:10571954,
FT                                ECO:0000269|PubMed:17908927}.
FT                                /FTId=VAR_009231.
FT   VARIANT    1487   1487       R -> G (in dbSNP:rs12118058).
FT                                /FTId=VAR_028055.
FT   CONFLICT   1398   1398       W -> G (in Ref. 1; AAB41040, 2; AAB48466/
FT                                AAB48467/AAB48468/AAB48469/AAB48470 and
FT                                3). {ECO:0000305}.
SQ   SEQUENCE   1532 AA;  174764 MW;  9BF1BCC43B7904D3 CRC64;
     MGHSKQIRIL LLNEMEKLEK TLFRLEQGYE LQFRLGPTLQ GKAVTVYTNY PFPGETFNRE
     KFRSLDWENP TEREDDSDKY CKLNLQQSGS FQYYFLQGNE KSGGGYIVVD PILRVGADNH
     VLPLDCVTLQ TFLAKCLGPF DEWESRLRVA KESGYNMIHF TPLQTLGLSR SCYSLANQLE
     LNPDFSRPNR KYTWNDVGQL VEKLKKEWNV ICITDVVYNH TAANSKWIQE HPECAYNLVN
     SPHLKPAWVL DRALWRFSCD VAEGKYKEKG IPALIENDHH MNSIRKIIWE DIFPKLKLWE
     FFQVDVNKAV EQFRRLLTQE NRRVTKSDPN QHLTIIQDPE YRRFGCTVDM NIALTTFIPH
     DKGPAAIEEC CNWFHKRMEE LNSEKHRLIN YHQEQAVNCL LGNVFYERLA GHGPKLGPVT
     RKHPLVTRYF TFPFEEIDFS MEESMIHLPN KACFLMAHNG WVMGDDPLRN FAEPGSEVYL
     RRELICWGDS VKLRYGNKPE DCPYLWAHMK KYTEITATYF QGVRLDNCHS TPLHVAEYML
     DAARNLQPNL YVVAELFTGS EDLDNVFVTR LGISSLIREA MSAYNSHEEG RLVYRYGGEP
     VGSFVQPCLR PLMPAIAHAL FMDITHDNEC PIVHRSAYDA LPSTTIVSMA CCASGSTRGY
     DELVPHQISV VSEERFYTKW NPEALPSNTG EVNFQSGIIA ARCAISKLHQ ELGAKGFIQV
     YVDQVDEDIV AVTRHSPSIH QSVVAVSRTA FRNPKTSFYS KEVPQMCIPG KIEEVVLEAR
     TIERNTKPYR KDENSINGTP DITVEIREHI QLNESKIVKQ AGVATKGPNE YIQEIEFENL
     SPGSVIIFRV SLDPHAQVAV GILRNHLTQF SPHFKSGSLA VDNADPILKI PFASLASRLT
     LAELNQILYR CESEEKEDGG GCYDIPNWSA LKYAGLQGLM SVLAEIRPKN DLGHPFCNNL
     RSGDWMIDYV SNRLISRSGT IAEVGKWLQA MFFYLKQIPR YLIPCYFDAI LIGAYTTLLD
     TAWKQMSSFV QNGSTFVKHL SLGSVQLCGV GKFPSLPILS PALMDVPYRL NEITKEKEQC
     CVSLAAGLPH FSSGIFRCWG RDTFIALRGI LLITGRYVEA RNIILAFAGT LRHGLIPNLL
     GEGIYARYNC RDAVWWWLQC IQDYCKMVPN GLDILKCPVS RMYPTDDSAP LPAGTLDQPL
     FEVIQEAMQK HMQGIQFRER NAGPQIDRNM KDEGFNITAG VDEETGFVYG GNRFNCGTWM
     DKMGESDRAR NRGIPATPRD GSAVEIVGLS KSAVRWLLEL SKKNIFPYHE VTVKRHGKAI
     KVSYDEWNRK IQDNFEKLFH VSEDPSDLNE KHPNLVHKRG IYKDSYGASS PWCDYQLRPN
     FTIAMVVAPE LFTTEKAWKA LEIAEKKLLG PLGMKTLDPD DMVYCGIYDN ALDNDNYNLA
     KGFNYHQGPE WLWPIGYFLR AKLYFSRLMG PETTAKTIVL VKNVLSRHYV HLERSPWKGL
     PELTNENAQY CPFSCETQAW SIATILETLY DL
//
